The National Institute for Innovation in Manufacturing Biopharmaceuticals ( NIIMBL ) announces the selection of 100 first- and second-year college students to participate in the 2025 NIIMBL experience program. Students were selected from 75 academic institutions across the United States and Puerto Rico to take part in one of seven NIIMBL eXperience...
Today, Commissioners from the National Security Commission on Emerging Biotechnology (NSCEB), along with Senator Chris Coons (D-DE) and Representative Sarah McBride (D-DE), visited the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) to see firsthand how government and industry partnerships drive excellence in...
The NIIMBL eXperience is an exclusive in-person, all expenses paid immersion program that offers you real-world insight into biopharmaceutical industry careers through hands-on activities and direct interactions with industry professionals. The program targets African American/Black, Latinx, and Native...
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has awarded over $200k in funding to launch the 2023 NIIMBL eXperience program in three distinct locations across the United States. Funding recipients include Albany College (ACPHS) in New York, BioKansas in the Kansas/Missouri Region, and Raritan Valley Community...
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) in collaboration with BioPhorum is pleased to announce that the data and design specification for the NIIMBL BioPhorum Buffer Stock Blending System are now publicly available for open-source use. This new current good manufacturing practices (cGMP) buffer technology...
